Cuicui Lyu
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Hematology top 10%
- Platelet Disorders and Treatments
Papers in
- Oncology 16
- CAR-T cell therapy research 14
- Hematology 10
- Platelet Disorders and Treatments 7
- Blood groups and transfusion 4
- Hemophilia Treatment and Research 2
- Co-authors
- Wenyi Lu (6 shared papers)Qi Deng (9 shared papers)Mingfeng Zhao (5 shared papers)Ting Yuan (1 shared paper)Xiaoyuan He (2 shared papers)Xin Jin (2 shared papers)Rui Sun (3 shared papers)Renchi Yang (11 shared papers)
- Journals
- Frontiers in Oncology (3 papers)Hematological Oncology (2 papers)Frontiers in Immunology (2 papers)Annals of Hematology (2 papers)Cell Transplantation (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Cuicui Lyu
33 papers receiving 479 citations
Peers
Comparison fields: 5 of 51
- Oncology 259
- Hematology 74
- Immunology 84
- Business and International Management 9
- Genetics 85
Countries citing papers authored by Cuicui Lyu
This map shows the geographic impact of Cuicui Lyu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuicui Lyu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuicui Lyu more than expected).
Fields of papers citing papers by Cuicui Lyu
This network shows the impact of papers produced by Cuicui Lyu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuicui Lyu. The network helps show where Cuicui Lyu may publish in the future.
Co-authors
The 25 scholars most cited alongside Cuicui Lyu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 116 | |
| 2 | 2018 | 84 | |
| 3 | 2020 | 40 | |
| 4 | 2021 | 24 | |
| 5 | 2021 | 24 | |
| 6 | 2024 | 23 | |
| 7 | 2020 | 22 | |
| 8 | 2015 | 17 | |
| 9 | 2018 | 15 | |
| 10 | 2017 | 13 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 10 | |
| 13 | 2022 | 10 | |
| 14 | 2019 | 9 | |
| 15 | 2015 | 9 | |
| 16 | Synergistic effect of programmed death-1 inhibitor and programmed death-1 ligand-1 inhibitor combined with chemotherapeutic drugs on DLBCL cell lines in vitro and in vivo. | 2020 | 8 |
| 17 | 2016 | 6 | |
| 18 | 2023 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2014 | 4 |
About Cuicui Lyu
Cuicui Lyu is a scholar working on Oncology, Hematology, Molecular Biology, Electrical and Electronic Engineering and Pulmonary and Respiratory Medicine, having authored 33 papers that have together received 481 indexed citations. Recurring topics across this work include CAR-T cell therapy research (14 papers), Platelet Disorders and Treatments (7 papers), Blood groups and transfusion (4 papers), Virus-based gene therapy research (3 papers), Hemophilia Treatment and Research (2 papers), Silicon Carbide Semiconductor Technologies (2 papers), Pluripotent Stem Cells Research (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Oncology (259 citations), Hematology (74 citations), Immunology (84 citations), Business and International Management (9 citations) and Genetics (85 citations). Cuicui Lyu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Wenyi Lu, Qi Deng, Mingfeng Zhao, Ting Yuan, Xiaoyuan He, Xin Jin, Rui Sun, Renchi Yang, Lin Cheng and Luqiao Wang. Their work appears in journals such as Frontiers in Oncology, Hematological Oncology, Frontiers in Immunology, Annals of Hematology and Cell Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.